Advanced search
Start date
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Absence of neutralizing antibodies against the Omicron SARS-CoV-2 variant in convalescent sera from individuals infected with the ancestral SARS-CoV-2 virus or its Gamma variant

Full text
Show less -
Lucy Santos Villas-Boas ; Anderson Vicente de Paula ; Almir Ribeiro da Silva Jr. ; Heuder Gustavo Oliveira Paiao ; Tania Regina Tozetto-Mendoza ; Erika Regina Manuli ; Fábio Eudes Leal [7] ; Andrea de Barros Coscelli Ferraz [8] ; Ester Cerdeira Sabino ; Ana Luiza Bierrenbach [10] ; Steven Sol Witkin [11] ; Maria Cassia Mendes-Correa
Total Authors: 12
Document type: Journal article
Source: Clinics; v. 77, 2022-08-08.

Abstract Objectives: The aim of the present study was to evaluate if neutralizing antibody responses induced by infection with the SARS-CoV-2 strain that was dominant at the beginning of the pandemic or by the Gamma variant was effective against the Omicron variant. Methods: Convalescent sera from 109 individuals, never exposed to a SARS-CoV-2 vaccine, who had mild or moderate symptoms not requiring hospitalization following either a documented SARS-CoV-2 ancestral strain infection or a Gamma variant infection, were assayed for in vitro neutralizing antibody activity against their original strains and the Omicron variant. Results: Following an infection with the ancestral strain, 56 (93.3%), 45 (77.6%) and 1 (1.7%) serum sample were positive for neutralizing antibodies against the ancestral, Gamma variant, and Omicron variant, respectively. After infection with the Gamma variant, 43 (87.8%) and 2 (4.1%) sera were positive for neutralizing antibodies against the Gamma and Omicron variants, respectively. Conclusions: Neutralizing antibodies generated following mild or moderate infection with the SARS-CoV-2 ancestral strain or the Gamma variant are not protective against the Omicron variant. HIGHLIGHTS Individuals previously infected with SARS-CoV-2 ancestral strain do not develop neutralizing antibodies against the Omicron variant. Omicron variant escapes immune response after SARS CoV-2 previous infection with the SARS CoV-2 Gamma variant. Individuals previously infected with SARS-CoV-2 ancestral strain or with SARS-CoV-2 Gamma variant will likely have little protection if subsequently exposed to the Omicron variant. (AU)

FAPESP's process: 20/05623-0 - SARS-CoV2 detection, in different biological specimens, among people infected with this virus
Grantee:Maria Cássia Jacintho Mendes Corrêa
Support Opportunities: Regular Research Grants